Sang A on harsh backlash against KDB over M&A issue.

Sang A pharmaceutical company strongly wished to make the M&A process in an open public bidding, but they denounced the Korea Development Bank (KDB) because the KDB only attempted to decline it just for the sake of their own interests.

Sang A therefore took a rally in front of the KDB and the Grand National Party, claiming that they could not get the M&A any longer if the open public bidding...